PLoS Computational Biology (Jul 2021)

OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.

  • Robert Hinch,
  • William J M Probert,
  • Anel Nurtay,
  • Michelle Kendall,
  • Chris Wymant,
  • Matthew Hall,
  • Katrina Lythgoe,
  • Ana Bulas Cruz,
  • Lele Zhao,
  • Andrea Stewart,
  • Luca Ferretti,
  • Daniel Montero,
  • James Warren,
  • Nicole Mather,
  • Matthew Abueg,
  • Neo Wu,
  • Olivier Legat,
  • Katie Bentley,
  • Thomas Mead,
  • Kelvin Van-Vuuren,
  • Dylan Feldner-Busztin,
  • Tommaso Ristori,
  • Anthony Finkelstein,
  • David G Bonsall,
  • Lucie Abeler-Dörner,
  • Christophe Fraser

DOI
https://doi.org/10.1371/journal.pcbi.1009146
Journal volume & issue
Vol. 17, no. 7
p. e1009146

Abstract

Read online

SARS-CoV-2 has spread across the world, causing high mortality and unprecedented restrictions on social and economic activity. Policymakers are assessing how best to navigate through the ongoing epidemic, with computational models being used to predict the spread of infection and assess the impact of public health measures. Here, we present OpenABM-Covid19: an agent-based simulation of the epidemic including detailed age-stratification and realistic social networks. By default the model is parameterised to UK demographics and calibrated to the UK epidemic, however, it can easily be re-parameterised for other countries. OpenABM-Covid19 can evaluate non-pharmaceutical interventions, including both manual and digital contact tracing, and vaccination programmes. It can simulate a population of 1 million people in seconds per day, allowing parameter sweeps and formal statistical model-based inference. The code is open-source and has been developed by teams both inside and outside academia, with an emphasis on formal testing, documentation, modularity and transparency. A key feature of OpenABM-Covid19 are its Python and R interfaces, which has allowed scientists and policymakers to simulate dynamic packages of interventions and help compare options to suppress the COVID-19 epidemic.